In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, Explore the Benefits of BPC 157 Nugenyx Unlocking Healing Potential: Benefits of BPC 157 Peptide Therapy Albano Clinic US FDA is expected to lift restriction on certain peptides, NYT reports Reuters Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law